|
|
TAN 26 HM 0432
|
Imatinib Mesylate
|
Imatinib mesylate 400 mg,Isopropyl Alcohol q.s ml,Magnesium Stearate 1.60 mg/6 mL,Opadry Brown 02F86982 9.60 mg/6 mL,Povidone K-30 0.40 mg/6 mL
|
SHILPA MEDICARE LIMITED
|
Registered/Compliant
|
Details →
|
|
|
TAN 26 HM 0510
|
Bortezomib 3.5 mg/vial powder for solution for injection
|
Bortezomib 3.5 mg/vial,Mannitol (Pyrogen free) 35.0 mg/6 mL,Tertiary Butyl Alcohol 0.6 ml,Water for Injection Q. s to 2.0 ml
|
SHILPA MEDICARE LIMITED
|
Registered/Compliant
|
Details →
|
|
|
TAN 23 HM 0184
|
Irinotecan Hydrochloride 20 mg/mL Concentrate for Solution for Infusion (5 mL)
|
Hydrochloric acid q.s to pH 3.5 ml,Irinotecan hydrochloride trihydrate equivalent to Irinotecan 20 mg/0.05ml,Lactic acid [90%] 0.9 mg/6 mL,Sodium Hydroxide, q.s to pH 3.5 mg/6 mL,Sorbitol 400 [Low Endotoxin] 45.0 mg/6 mL,Water for Injection q.s to 1.0 ml
|
SHILPA MEDICARE LIMITED
|
Registered/Compliant
|
Details →
|
|
|
TAN 22 HM 0476
|
GEMCITABINE 38 MG/ML sterile concentrate for injection
|
Gemcitabine Hydrochloride 200 mg/5.26 ml
|
SHILPA MEDICARE LIMITED
|
Registered/Compliant
|
Details →
|
|
|
TAN 22 HM 0475
|
Gemcitabine 38 mg/mL concentrate for solution for infusion
|
Gemcitabine Hydrochloride 1g/26.3 ml
|
SHILPA MEDICARE LIMITED
|
Registered/Compliant
|
Details →
|
|
|
TAN 23 HM 0238
|
Capecitabine
|
Capecitabine 500 mg
|
SHILPA MEDICARE LIMITED (UNIT IV)
|
Registered/Compliant
|
Details →
|